E2 ModeratePreliminaryPEM unclearCross-SectionalPeer-reviewedMachine draft
Brain MR in chronic fatigue syndrome.
Greco, A, Tannock, C, Brostoff, J et al. · AJNR. American journal of neuroradiology · 1997
Quick Summary
Researchers used brain MRI scans to look for white matter abnormalities (areas of damage in the brain's connecting tissue) in 43 ME/CFS patients and compared them to 43 healthy control subjects. While some abnormalities were found in both groups, there was no pattern of brain changes that was unique to ME/CFS, suggesting that MRI scans alone cannot diagnose the condition.
Why It Matters
This study addresses a critical diagnostic need in ME/CFS: whether brain imaging can objectively identify the condition or distinguish it from psychiatric comorbidities. Understanding the prevalence and specificity of structural brain changes helps clarify whether ME/CFS has identifiable neurobiological markers and informs expectations about what brain imaging can reveal.
Observed Findings
- 32% of ME/CFS patients showed white matter abnormalities on MRI compared to 28% of controls (not statistically different).
- Two patients showed demyelination patterns in periventricular white matter, one with CFS alone and one with CFS and depression.
- Younger patients (ages 34-48) displayed punctate hyperintense foci in corona radiata, centrum ovale, and frontal white matter.
- Older patients (ages 50-78) showed frontoparietal subcortical white matter foci of high T2 signal.
- No MRI pattern was specific to or characteristic of CFS.
Inferred Conclusions
- White matter hyperintensities occur in both ME/CFS patients and healthy controls at similar rates, indicating they are not specific to the disease.
- MRI cannot serve as a diagnostic biomarker for ME/CFS based on white matter abnormalities alone.
- White matter changes in ME/CFS patients may reflect age-related or incidental findings rather than disease-specific pathology.
Remaining Questions
- Do white matter abnormalities correlate with symptom severity, disease duration, or functional impairment in ME/CFS patients?
- Could more sensitive MRI sequences (e.g., diffusion tensor imaging, spectroscopy) detect disease-specific microstructural changes not visible on standard MRI?
What This Study Does Not Prove
This study does not prove that white matter abnormalities are absent in ME/CFS, only that they are not specific to the condition and occur at similar rates in healthy controls. The study cannot determine whether observed changes cause symptoms or are clinically meaningful. Cross-sectional design prevents assessment of whether brain abnormalities develop over disease course or correlate with disease severity.
Tags
Symptom:Cognitive DysfunctionFatigue
Biomarker:Neuroimaging
Method Flag:PEM Not DefinedSmall SampleMixed Cohort
Metadata
- PMID
- 9282853
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →